Thursday, May 25, 2017
 
 
Unmet Medical Needs in Emerging Nations to Provide Considerable Growth Opportunities for Point-of-care Diagnostics Market
The top four players cumulatively accounted for a little short of 80% of the global point-of-case diagnostics market in 2015, rendering its vendor landscape highly cons...
 
Athenex and Its Partner, Guangzhou Xiangxue Pharmaceutical, Announced Chinese FDA IND Approval to Begin Clinical Trials of KX-02 Tablet for Glioblastoma
BUFFALO, N.Y., May 24, 2017 /PRNewswire/ -- Athenex, Inc., Buffalo, NY, a global specialty oncology pharmaceutical company focusing on the development and commercialization of next generation therapies for cancers and supportive therapies, announced today that its partner, Guangzhou Xiangxue P.....
 
Broad Institute To Release Genome Analysis Toolkit 4 (GATK4) As Open Source Resource To Accelerate Research
CAMBRIDGE, Mass., May 24, 2017 /PRNewswire/ -- The Broad Institute of MIT and Harvard will release version 4 of the industry-leading Genome Analysis Toolkit under an open source software license. The software package, designated GATK4, contains new tools and rebuilt arch.....
 
New York State Issues Approval for the Guardant360 Assay
REDWOOD CITY, Calif., May 24, 2017 /PRNewswire/ -- Guardant Health announced that the Guardant360® assay has been approved by New York State's Clinical Laboratory Evaluation Program (CLEP). The Guardant360 assay is now the first and only comprehensive liquid biopsy permitted by the
 
$100 million gift establishes Duchossois Family Institute to develop 'new science' focused on optimizing health
CHICAGO, May 24, 2017 /PRNewswire-USNewswire/ -- A Chicago-area family with a deep commitment to supporting science and medicine is giving $100 million to establish The Duchossois Family Institute at the University of Chicago Medicine, .....
 
Sensus Healthcare Awarded 2017 Technology Leader of the Year for Disruptive Technology from Greater Miami Chamber of Commerce

BOCA RATON, Fla., May 24, 2017 /PRNewswire/ -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions, such as keloids with Superficial Radioth.....

 



Testosterone Pellets Help Women Face Age-Related Conditions, Improve Sex Drive
CHICAGO, May 24, 2017 /PRNewswire/ -- When hormones are out of control, many women turn to pills, patches or injections. But one Chicago doctor is using hormone pellets with testosterone to add balance to his patients' lives.
 
DERMABOND® PRINEO® Skin Closure System May Improve Outcomes and Lower Hospital Costs
SOMERVILLE, N.J., May 24, 2017 /PRNewswire/ -- Ethicon* announced the results of two economic analyses demonstrating that the DERMABOND® PRINEO® Skin Closure system, a product that combines a topical skin adhesive with a self-adhering patch, is associated with improved patient outcomes and low.....
 
ASI's Advanced Algorithms Automatically Interpret PD-L1 Assays
CARLSBAD, California, May 24, 2017 /PRNewswire/ -- Applied Spectral Imaging (ASI), a global leader in computer-assisted image analysis platforms, introduces HiPath for analysis of PD-L1 assays.
 
Damon Runyon Cancer Research Foundation to Hold 9th Annual Runyon 5K at Yankee Stadium on Saturday, July 15
BRONX, New York, May 24, 2017 /PRNewswire/ -- On Saturday, July 15, 2017, the Damon Runyon Cancer Research Foundation will hold the 9th Annual Runyon 5K at Ya.....
 
Oncolytics Biotech® Prices Public Offering of Units

CALGARY, May 24, 2017 /PRNewswire/ - Oncolytics Biotech® Inc. (Oncolytics or the Company) (TSX:ONC) (OTCQX:ONCYF) today announced the pricing of an underwritten public offering of 14,300,000 units (Units) at a purchase price of $0.70 per Unit for gross proceeds of

 
OncoQuest to Present Oregovomab Phase II Interim Clinical Results for Front Line Treatment of Ovarian Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting
EDMONTON, May 24, 2017 /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a privately held, biopharmaceutical company focused on the development and commercialization of immunotherapeutic products for the treatment of cancer, today announced the presentation of initial safety and efficacy data from the company's multi.....
 
Harrington Discovery Institute at University Hospitals Opens Call for Harrington Rare Disease Scholar Award

CLEVELAND, May 24, 2017 /PRNewswire/ -- Harrington Discovery Institute at University Hospitals in Cleveland, Ohio part of The Harrington Project for Discovery & Development is pleased to announce its request for proposals for the Harrington Rare Disease Scholar Award. The Harr.....

 
Terumo BCT Joins CANCER-ID Consortium
LAKEWOOD, Colo., May 24, 2017 /PRNewswire/ -- Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, today announced it has joined CANCER-ID, a.....
 


 
 
 
 
 
 
 
 
 
 
 





About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines